Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery

Anesthesiology

Volumn 112, Issue 1, 2010, Pages 128-137

  Beaulieu, Yanick ^a   Denault, André Y ^a,b   Couture, Pierre ^a   Roy, Denis ^a   Talajic, Mario ^a   O'Meara, Eileen ^a   Carrier, Michel ^a   Pagé, Pierre ^a   Levesque, Sylvie ^a   Lambert, Jean ^c   Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CALCIUM CHANNEL BLOCKING AGENT; PLACEBO; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART RATE; HEART SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANESTHESIA; BIOASSAY; CARDIOPULMONARY BYPASS; DRUG EFFECT; HEART VALVE; HEART VALVE REPLACEMENT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

AGED; AMIODARONE; ANESTHESIA; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HEART RATE; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 74049138660     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181c61b28     Document Type: Article

References (22)

1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT: A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-1729
2. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, Kidd WT, Kieser T, Burgess JJ, Ferland A, MacAdams CL, Maitland A: Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revas-cularization, valve replacement, or repair: PAPABEAR: A randomized controlled trial JAMA 2005; 294:3093-3100
3. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR: Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94:390-397
4. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, Browner WS: Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276:300-306
5. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, Lopez JA, Rasekh A, Wilson JM, Massumi A: Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43:742-748
6. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Morady F: Preop-erative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337:1785-1791
7. DiDomenico RJ, Massad MG: Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg 2005; 79:728-740
8. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR: Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 1999; 34:343-347
9. Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, Tsikouris JP, Wilcox HA, Kluger J: Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): A randomised placebo-controlled trial. Lancet 2001; 357:830-836 (Pubitemid 32239367)
10. White CM, Giri S, Tsikouris JP, Dunn A, Felton K, Reddy P, Kluger J: A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg 2002; 74:69-74
11. White CM, Caron MF, Kalus JS, Rose H, Song J, Reddy P, Gallagher R, Kluger J: Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: The atrial fibrillation suppression trial II (AFIST II). Circulation 2003; 108(suppl 1):II200-6
12. Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG: Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: A meta-analysis. Ann Intern Med 2005; 143:327-336
13. Piquette D, Deschamps A, Belisle S, Pellerin M, Levesque S, Tardif JC, Denault AY: Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery: [L'effet de la nitroglycerine intraveineuse sur la saturation cere-brale dans les chirurgies cardiaques a haut risque]. Can J Anaesth 2007; 54:718-727
14. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, Mc-Namara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104:2118-2150
15. Hohnloser SH, Meinertz T, Dammbacher T, Steiert K, Jahnchen E, Zehender M, Fraedrich G, Just H: Electrocar-diographic and antiarrhythmic effects of intravenous ami-odarone: Results of a prospective, placebo-controlled study. Am Heart J 1991; 121:89-95
16. Butler J, Harriss DR, Sinclair M, Westaby S: Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomised, double blind, placebo controlled trial. Br Heart J 1993; 70:56-60
17. Fuller JA, Adams GG, Buxton B: Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989; 97:821-825
18. Leitch JW, Thomson D, Baird DK, Harris PJ: The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100:338-342
19. Belhassen B, Viskin S, Laniado S: Sustained atrial fibrillation after conversion of paroxysmal reciprocating junc-tional tachycardia by intravenous verapamil. Am J Cardiol 1988; 62:835-837
20. Falk RH, Knowlton AA, Manaker S: Verapamil-induced atrial fibrillation. N Engl J Med 1988; 318:640-641
21. Garratt C, Ward D, Camm AJ: Degeneration of junctional tachycardia to pre-excited atrial fibrillation after intravenous verapamil. Lancet 1989; 2:219
22. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R: Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988; 62:403-407